Nemaura Medical Overview
- Year Founded
-
2011
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
NMRD
Nemaura Medical General Information
Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable, and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin patch connected to a rechargeable transmitter with an app displaying glucose readings at five-minute intervals for periods up to 24 hours.
Contact Information
Website
www.nemauramedical.comCorporate Office
- 57 West 57th Street
- New York, NY 10019
- United States
Corporate Office
- 57 West 57th Street
- New York, NY 10019
- United States
Nemaura Medical Timeline
Nemaura Medical Stock Performance
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 2.45K |
Nemaura Medical Financials Summary
As of 31-Dec-2023, Nemaura Medical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Dec-2023 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 |
|---|---|---|---|---|
| EV | 25,862 | 38,594 | 105,847 | 165,537 |
| Revenue | 0 | 77 | 504 | 0 |
| EBITDA | (4,498) | (7,287) | (7,341) | (4,489) |
| Net Income | (10,651) | (14,144) | (13,887) | (6,259) |
| Total Assets | 5,169 | 14,563 | 22,102 | 35,243 |
| Total Debt | 19,643 | 20,030 | 19,189 | 24,922 |
Nemaura Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nemaura Medical Comparisons
Industry
Financing
Details
Nemaura Medical Competitors (4)
One of Nemaura Medical’s 4 competitors is GlySens, a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GlySens | Venture Capital-Backed | San Diego, CA | ||||
| Medtrum | Venture Capital-Backed | Shanghai, China | ||||
| DexCom | Formerly VC-backed | San Diego, CA | ||||
| Abbott | Corporation | Abbot Park, IL |
Nemaura Medical Signals
Nemaura Medical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Nemaura Medical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Nemaura Medical FAQs
-
When was Nemaura Medical founded?
Nemaura Medical was founded in 2011.
-
Where is Nemaura Medical headquartered?
Nemaura Medical is headquartered in New York, NY.
-
What is the size of Nemaura Medical?
Nemaura Medical has 38 total employees.
-
What industry is Nemaura Medical in?
Nemaura Medical’s primary industry is Diagnostic Equipment.
-
Is Nemaura Medical a private or public company?
Nemaura Medical is a Public company.
-
What is Nemaura Medical’s stock symbol?
The ticker symbol for Nemaura Medical is NMRD.
-
Who are Nemaura Medical’s competitors?
GlySens, Medtrum, DexCom, and Abbott are competitors of Nemaura Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process